[1] |
Guo Hao, Zhuang Huicui, Yang Limei, Ren Jing, Cui Dongsheng, Zhang Liran.
2019-2021 pathogen infection characteristics and drug resistance analysis on patients from Intensive Care Unit of the Hospital
[J]. Clinical Focus, 2022, 37(6): 519-524.
|
[2] |
Zhu Ying, Shu Qianqian, Chen Fuhui.
Clinical characteristics and drug resistance of community-acquired Acinetobacter baumannii pneumonia
[J]. Clinical Focus, 2022, 37(4): 315-319.
|
[3] |
He Ping, Fang Ruiying, Huang Lili, Zheng Xiuxiu, Tao Yunzhen.
Distribution of pathogenic bacteria infected on children with otitis media in SuZhou from 2012 to 2020 and change in corresponding drug resistance
[J]. Clinical Focus, 2022, 37(4): 343-348.
|
[4] |
Shi Xiaochun, Liu Xiaoqing.
Clinical analysis of Staphylococcus infective endocarditis: 46 cases report
[J]. Clinical Focus, 2022, 37(2): 124-127.
|
[5] |
Li Chaojun, Sun Chenghong, Jin Wenyu.
Comparation of CT imaging characteristics between non-tuberculous mycobacterium tuberculosis and multi-drug resistant tuberculosis
[J]. Clinical Focus, 2021, 36(6): 530-534.
|
[6] |
Yu Xiaoxia, Wang Qiaohong.
Clinical analysis and therapy on urinary tract infection in children
[J]. Clinical Focus, 2021, 36(2): 153-156.
|
[7] |
Shen Ziyuan, Kang Haiquan, Sang Wei, Yan Dongmei.
Analysis of bacterial distribution, resistance and risk factor of death of bacterial infection in leukemia patients
[J]. Clinical Focus, 2021, 36(12): 1092-1096.
|
[8] |
Lin Na, Liu Chuan, Wu Tianyu, Cao Lei.
A case of acute hemorrhagic cerebral infarction caused by infective endocarditis
[J]. Clinical Focus, 2021, 36(1): 66-69.
|
[9] |
Lu Tao1, Ni Li1, Seto Waikay1, 2, Liu Jun3, Guo Haijian3, Wu Jianwei4, Lu Zhiwu4, Li Yinpeng5, Yang Qiu5, Yu Xiqiu6.
A multicenter study of antibiotic resistance characteristics of Helicobacter pylori in Shenzhen
[J]. Clinical Focus, 2020, 35(8): 714-718.
|
[10] |
Zhan Yaping, Li Xian, Zhu Xiangshun, Wang Guofen, Tong Xiaojun.
Clinical analysis of adjuvant therapy of bifidobacterium quadruple bacteria in hyperuricemia
[J]. Clinical Focus, 2020, 35(4): 344-347.
|
[11] |
Yin Haiqing1a, Yao Baoguo2a, Chen Wanzhen1b, Su Li2b.
Risk factors and drug resistance of Carbapenemresistant Enterobacter in malignant tumor patients
[J]. Clinical Focus, 2020, 35(2): 166-169.
|
[12] |
He Ping, Feng Tao, Xu Jun, Hua Shenghao, Huang Lili, Shao Xuejun, Zhu Hong, Ji Xueqiang.
Distribution and drug resistance characteristics of bronchoalveolar lavage fluid in hospitalized children with pneumonia in Soochow 2013-2018
[J]. Clinical Focus, 2019, 34(9): 809-813.
|
[13] |
Wang Na, Zhu Yugang, Liu Weiguang, Wang Defeng.
Standardized antibiotic therapy for diabetic foot
[J]. Clinical Focus, 2019, 34(8): 702-706.
|
[14] |
Liu Qimeng, Ye Huan.
Risk factors for Carbapenemresistant and mortality in inpatients with pneumonia due to gramnegative bacteria
[J]. Clinical Focus, 2019, 34(4): 334-338.
|
[15] |
Zhang Pan, Xie Shoujun, Wen Hainan.
Distribution and drug resistance analysis of 1 113 strains of bloodstream infection
[J]. Clinical Focus, 2019, 34(2): 148-153.
|